Gilead’s Remdesivir Brought In $873 Million During The Third Quarter

By Staff of CNBC
Wednesday, October 28, 2020 4:51 PM EDT

Meg Tirrell joins ‘Closing Bell’ to talk about Gilead’s quarterly earnings.

How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.